Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Has results × Dermatomyositis × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1139 Prostatic Neoplasms 625 Neoplasms 576 Carcinoma, Non-Small-Cell Lung 482 Multiple Myeloma 474 Leukemia, Myeloid, Acute 450 Leukemia 417 Lung Neoplasms 396 Lymphoma 378 Leukemia, Lymphocytic, Chronic, B-Cell 331 Precursor Cell Lymphoblastic Leukemia-Lymphoma 322 Lymphoma, Non-Hodgkin 321 Pancreatic Neoplasms 302 Colorectal Neoplasms 302 Neoplasm Metastasis 300 Myelodysplastic Syndromes 298 Melanoma 280 Hodgkin Disease 249 Head and Neck Neoplasms 242 Brain Neoplasms 229 Lymphoma, Follicular 221 Ovarian Neoplasms 218 Recurrence 217 Lymphoma, Mantle-Cell 210 Glioblastoma 209 Lymphoma, Large B-Cell, Diffuse 206 Squamous Cell Carcinoma of Head and Neck 170 Colonic Neoplasms 161 Carcinoma, Renal Cell 155 Carcinoma, Hepatocellular 153

Interventions

Sodium Chloride 1 Etanercept 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00112385 2011-06-21

A Pilot Study of Etanercept in Dermatomyositis

Brigham and Women's Hospital

Phase 1 Completed

16 enrolled 42 charts

Dermatomyositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡